Ilant founder and CEO Elina Onitskansky
June 2, 2026 06:00 AM EDT
FinancingStartupsHealth Tech
Exclusive: Obesity care startup Ilant Health raises $15M
Shelby Livingston
Ilant Health has raised a $15M Series A funding round to expand its personalized approach to treating obesity.
Ilant Health closes $15M Series A for personalized obesity care, capitalizing on GLP-1 drug boom. Signal for tech leads: obesity shifts from pharma-only to persistent tech platforms requiring AI decision support and EHR integration—healthcare IT budgets expand.
Ilant founder and CEO Elina Onitskansky
June 2, 2026 06:00 AM EDT
FinancingStartupsHealth Tech
Exclusive: Obesity care startup Ilant Health raises $15M
Shelby Livingston

Function Health, a company that offers lab testing and body scans for early disease detection, landed $450 million in growth…

Who got exclusive access to Eli Lilly's highly anticipated obesity candidate? And why are drugmakers spending so much on…

Signos, a startup that aims to help people lose weight by understanding their blood sugar, has raised a new $20 million round of…

Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And…

A new startup is making a bold move in the world of obesity drug development: It’s not working with the GLP-1 target that has…

Virtual care platform First Stop Health unveiled an expansion of its Healthy Weight Program amid increasing GLP-1 demand and…